Study Finds Newer 340B Public Hospitals More Likely to Increase Unprofitable Service Lines Than Newer Non-Profit Hospitals

Government-owned 340B hospitals recently enrolled in 340B were more likely to increase unprofitable services than new 340B nonprofit hospitals, a recent study found.
While newly enrolled 340B hospital entrants served higher numbers of Medicaid and rural patients than non-340B hospitals, government-owned 340B hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Eight More Provider Audits Closed with Corrective Action Plans in Latest HRSA Audit Findings

HRSA's latest update to its ongoing fiscal year 2023 program integrity audits included corrective action plans for eight 340B providers.
Federal auditors closed audits with corrective action plans (CAPs) for eight more 340B providers, which brought the fiscal year 2023 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Novo to Extend Contract Pharmacy Restrictions to Grantees But Allow Them to Keep Access Under Conditions; Company Also Modifies Hospital Policy

Pharmaceutical manufacturer Novo Nordisk recently announced it will extend its 340B contract pharmacy restrictions to federal grantees.
Drugmaker Novo Nordisk this week announced that its contract pharmacy restrictions will soon apply to all grantee covered entities—not just [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Appeals Court Rejects PhRMA’s Request for a Full Panel Rehearing of Arkansas 340B Contract Pharmacy Case

The U.S. 8th Circuit Court of Appeals denied PhRMA's request to reconsider a decision upholding Arkansas' 340B law.
A federal appeals court today rejected a drug industry trade group’s request for all of its appellate judges to reconsider [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Arkansas Enforcing 340B Contract Pharmacy Access Law Against AstraZeneca

Arkansas officials are seeking penalties against AstraZeneca in an August hearing for allegedly violating the state's 340B contract pharmacy access law.
Arkansas state officials today scheduled a public hearing to enforce the state’s 340B contract pharmacy access law against AstraZeneca, according [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Loosens Contract Pharmacy Restrictions on Arkansas Hospitals

Takeda has loosened its 340B contract pharmacy restrictions for Arkansas-based hospital covered entities.
Editors’ note: After publication, Pfizer became the 24th drugmaker to loosen or end its contract pharmacy restrictions for Arkansas covered entities, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Bill Introduced to Expand 340B Eligibility to Outpatient-Focused Rural Emergency Hospitals

Rep. Debbie Dingell (D-Mich.), who sits on the House E&C Committee, co-sponsored legislation that would grant 340B eligibility to certain rural emergency hospitals.
Two federal lawmakers this week introduced bipartisan legislation that would extend 340B eligibility to certain outpatient-focused rural hospitals offering emergency [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Program Critics, Supporters Target States 

ALEC, a conservative legislative group that receives drug industry funding, is advocating against state 340B legislation. Provider groups have criticized the campaign and launched their own efforts in support of 340B state bills.
As 340B stakeholders continue to hold out for long-awaited congressional action that could overhaul the discount drug pricing program, some [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Group Critical of Medicare Negotiation and 340B Program Suggests 340B Providers May Avoid IRA Negotiated Lower-Cost Drugs

The American Action Forum published a policy insight that suggested 340B providers could avoid IRA-negotiated lower-cost drugs.
Medicare Part D plans and 340B providers may avoid drugs with negotiated lower Medicare prices to maximize revenue from rebates, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Troy Polan, Chief Information Officer, Avita Care Solutions

Troy Polan

Q: Where did you grow up?

I grew up in southern Connecticut and lived there my entire childhood.

Q: What are your favorites?

Food: Indian, pizza, soft-serve ice cream

Movie: Eternal Sunshine of the Spotless Mind, Anchorman, Raising Arizona

Musicians: Prince, Leon Bridges, Bob Dylan

Destinations: New Zealand, New York City, Switzerland

Q: What do you

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live